SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-209127
Filing Date
2023-08-10
Accepted
2023-08-10 16:51:31
Documents
5
Effectiveness Date
2023-08-10

Document Format Files

Seq Description Document Type Size
1 S-8 d516145ds8.htm S-8 54613
2 EX-5.1 d516145dex51.htm EX-5.1 8001
3 EX-23.1 d516145dex231.htm EX-23.1 1542
4 EX-FILING FEES d516145dexfilingfees.htm EX-FILING FEES 13154
5 GRAPHIC g516145g0808003210318.jpg GRAPHIC 2534
  Complete submission text file 0001193125-23-209127.txt   82161
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273887 | Film No.: 231160378
SIC: 2834 Pharmaceutical Preparations